Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine for relapse prevention after intravenous ketamine in treatment-resistant depression
IRCT2013110415276N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of lamotrigine and ketamine in treatment-resistant depression (TRD), sponsored by Tehran University of Medical Sciences. Started Sep 2014; status: completed.
02
Drugs
lamotrigineketamine
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on IRCT2013110415276N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013110415276N1.